SINTX TechnologiesSINT +3.78%27 PB Ratio is 8.81 as of Jun. 26, 2026, which is 827% above its 10-year median of 0.95. GuruFocus rates SINT with a GF Score™ of 27/100 and a GF Value™ of $0.15 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 788 Medical Devices & Instruments companies, SINTX Technologies ranks worse than 89.21% on this metric.
The historical rank and industry rank for SINTX Technologies's PB Ratio or its related term are showing as below:
SINT'
s PB Ratio Range Over the Past 10 Years
Min: 0.03 Med: 0.95 Max: 12.28
Current: 8.73
During the past 13 years, SINTX Technologies's highest PB Ratio was 12.28. The lowest was 0.03. And the median was 0.95.
SINT's PB Ratio is ranked worse than 89.21% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.02
vs SINT: 8.73
During the past 12 months, SINTX Technologies's average Book Value Per Share Growth Rate was -91.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -92.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -89.90% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of SINTX Technologies was -76.70% per year. The lowest was -94.50% per year. And the median was -92.70% per year.
Back to Basics: PB Ratio
SINTX Technologies (NAS:SINT) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
SINTX Technologies PB Ratio Related Terms
SINTX Technologies PB Ratio Historical Data
* Premium members only.
The historical data trend for SINTX Technologies's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, SINTX Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SINTX Technologies PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SINTX Technologies's PB Ratio distribution charts can be found below:
* The bar in red indicates where SINTX Technologies's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
SINTX Technologies (SINT) has a PB Ratio of 8.81 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on SINTX Technologies and its competitors. This is 827% above median its historical median of 0.95. Over the past decade, SINTX Technologies' PB Ratio has ranged from 0.03 to 12.28. According to the industry distribution chart, SINTX Technologies ranks #703 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 89.2%.
Is SINTX Technologies' PB Ratio too high?
SINTX Technologies' current PB Ratio of 8.81 is 827% above median its 10-year median of 0.95. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 12.28. The Medical Devices & Instruments industry median PB Ratio is 2.02. SINTX Technologies' value of 8.81 is 336.1% above this industry median. Based on the distribution chart, SINTX Technologies ranks #703 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SINTX Technologies has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SINTX Technologies' PB Ratio compare to VVOS and AIDX?
According to the Medical Devices & Instruments industry distribution chart, SINTX Technologies ranks #703 out of 788 companies for PB Ratio. This places SINTX Technologies in the lower half of its industry. The industry median PB Ratio is 2.02. SINTX Technologies' value of 8.81 is 336.1% above this benchmark. Historically, SINTX Technologies' own PB Ratio has ranged from 0.03 to 12.28 over the past decade. While the company's 10-year median is 0.95 vs. the industry median of 2.02, SINTX Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SINTX Technologies's current PB Ratio of 8.81 is 336.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on SINTX Technologies and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SINTX Technologies's current PB Ratio is 8.81, which is 827% above median its own 10-year median of 0.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SINTX Technologies stock overvalued right now?
Based on GuruFocus' analysis, SINTX Technologies (SINT) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.15, compared to a current price of $1.93 — trading 1186.7% above its estimated fair value. The current PB Ratio is 8.81, which is 827% above median its 10-year median of 0.95 and 336.1% above the Medical Devices & Instruments industry median of 2.02. SINTX Technologies' overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For SINTX Technologies (SINT), the current PB Ratio is 8.81 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SINTX Technologies (SINT) Overvalued in 2026?
Based on GuruFocus' analysis, SINTX Technologies stock appears to be overvalued.
The current stock price of $1.93 is trading 1186.7% above its estimated GF Value™ of $0.15.
GuruFocus considers SINTX Technologies to be Significantly Overvalued.
Key valuation signals for SINT:
PB Ratio: 8.81 (827% above median its 10-year median of 0.95)
GF Value™: $0.15 vs. price of $1.93 (1186.7% above fair value)
Industry Position: 336.1% above the Medical Devices & Instruments median (#703 of 788)
No single metric tells the full story. See the SINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.
27GF Score
Get the complete analysis for SINT
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SINT has been successfully added to your 
